Industry News

February 16, 2016

Recommendations for Donor Screening, Deferral, and Product Management to Reduce the Risk of Transfusion-Transmission of Zika Virus; Guidance for Industry.

FDA blood safety guidance for areas of active and non-active transmission of Zika virus

Any links to third party Web pages from this Web site are provided for your convenience only. Cerus does not monitor, author, edit, or endorse any information provided in these third party pages and assumes no responsibility for the accuracy of their content.

    Global Headquarters

  • 1220 Concord Avenue
  • Concord, CA US 94520
  • +1 925.288.6000

    European Headquarters

  • Stationsstraat 79-D
  • 3811 MH Amersfoort, Netherlands
  • +31 (0) 33 49 60 600